By George Vradenburg, Howard Fillit, MD and Michael W.Weiner, MD

Earlier this month, the Centers for Medicare and Medicaid Services (CMS) issued a draft Decision Memorandum to deny Medicare reimbursements to patients using an innovative FDA-approved Alzheimer's diagnostic technology designed to help physicians identify whether patients with signs of cognitive impairment may have Alzheimer's or are in fact suffering from another form of dementia. This information is vital to patients, their providers, choices regarding their treatment and their ultimate health outcomes.

New poll on expanded life finds most folks don't want to live past 120, Alzheimer's and oral health, and the death of a Latino civil rights leader from Alzheimer's (read more).      


Must reads

USAgainstAlzheimer's Associate Directors Virginia Biggar, Stephanie Monroe and Jennifer Molinoff appeared on the August 6 episode of Alzheimer's Speaks Radio to discuss the latest activities of ActivistsAgainstAlzheimer's, the African American Network Against Alzheimer's, and WomenAgainstAlzheimer's, and explain how individuals can get more involved. Listen to the whole show online here! 

Breast-feeding may lower mom's risk of developing Alzheimer's, nanotech Alzheimer's detection system, and how diet impacts Alzheimer's (read more). 


Must Read

Star-Ledger editorial calls on Congress to restore funding for medical research  first NIH grant awarded to the Institute for Dementia Research and Prevention at Pennington Biomedical Research Center, and hope in the R&D pipeline for Alzheimer's drugs (read more).


Must Reads


^ Back to Top